Join us for ODACon™ 2022 Supportive Care Summit in November!
Oncology Data Advisor™ invites you to attend this one-day virtual conference focusing on breast cancer. This virtual conference will provide expert perspectives on the mechanisms of action and efficacy/safety profiles of novel therapy classes, therapeutic selection based on individual patient and tumor characteristics, and approaches for anticipating and detecting symptoms and side effects.
- Antibody-drug conjugates
- CDK4/6 inhibitors
- HER2 tyrosine kinase inhibitors
- Immune checkpoint inhibitors
- Monoclonal antibodies
- PARP inhibitors
- PI3K inhibitors
The conference will begin at 10:00 am EST / 7:00 am PST on Saturday, November 12, 2022.
Conference attendees will receive 5.5 CME/NCPD/ILNA credits.
i3 Health is pleased to partner with the National Breast Cancer Foundation for ODACon 2022.
About National Breast Cancer Foundation, Inc.®
Recognized as one of the leading breast cancer organizations in the world, National Breast Cancer Foundation (NBCF) is Helping Women Now® by providing early detection, education, and support services to those affected by breast cancer. A recipient of Charity Navigator's highest 4-star rating for 16 years, NBCF provides support through their National Mammography Program, Patient Navigation, breast health education, and patient support programs. For more information, please visit https://www.nationalbreastcancer.org.